Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $16.71 Billion |
|---|---|
| Enterprise Value | $325.09 Billion |
| Annual dividend | $0.24 |
| Dividend yield | 2.46% |
| Earnings per Share | $127.83 |
| Beta | 0.03 |
| Outstanding Shares | 1,702,284,000 |
| P/E Ratio | 11.19 |
|---|---|
| PEG | -22.08 |
| Price to Sales | 0.03 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 0.51 |
| Enterprise Value to EBIT | 1.47 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 2.11 |
| Debt to Equity | 0.39 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 0.00% |
|---|---|
| Total Invested | $1.26M▼ 33.70% |
| Investors Holding | 5▼ 3.00% |
Shionogi & Co., Ltd., an Osaka, Japan-based pharmaceutical company established in 1878, focuses on the discovery, development, production, and commercialization of medicines, diagnostic tools, and medical devices primarily within Japan. ...